Cargando…

Gene-Gene Interactions Lead to Higher Risk for Development of Type 2 Diabetes in an Ashkenazi Jewish Population

BACKGROUND: Evidence has accumulated that multiple genetic and environmental factors play important roles in determining susceptibility to type 2 diabetes (T2D). Although variants from candidate genes have become prime targets for genetic analysis, few studies have considered their interplay. Our go...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuman, Rosalind J., Wasson, Jon, Atzmon, Gil, Wainstein, Julio, Yerushalmi, Yair, Cohen, Joseph, Barzilai, Nir, Blech, Ilana, Glaser, Benjamin, Permutt, M. Alan
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845632/ https://www.ncbi.nlm.nih.gov/pubmed/20361036 http://dx.doi.org/10.1371/journal.pone.0009903

Ejemplares similares

Ashkenazi Jewish Centenarians Do Not Demonstrate Enrichment in Mitochondrial Haplogroup J
por: Shlush, Liran I., et al.
Publicado: (2008)

Targeted sequencing of the 9p21.3 region reveals association with reduced disease risks in Ashkenazi Jewish centenarians
por: Zhu, Yizhou, et al.
Publicado: (2023)

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2018)

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population
por: Rivas, Manuel A., et al.
Publicado: (2019)

Carrier screening in individuals of Ashkenazi Jewish descent
por: Gross, Susan J., et al.
Publicado: (2008)

Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins
por: Carmi, Shai, et al.
Publicado: (2014)

A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci
por: Kenny, Eimear E., et al.
Publicado: (2012)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

High mammographic density in women of Ashkenazi Jewish descent
por: Caswell, Jennifer L, et al.
Publicado: (2013)

The time and place of European admixture in Ashkenazi Jewish history
por: Xue, James, et al.
Publicado: (2017)

Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications
por: Feder, Jeanette, et al.
Publicado: (2008)

Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020)

Implications for health and disease in the genetic signature of the Ashkenazi Jewish population
por: Guha, Saurav, et al.
Publicado: (2012)

Differences in MS clinical and epidemiological characteristics between Ashkenazi and non-Ashkenazi Jewish patients in Israel: a retrospective single center study
por: Karni, Arnon, et al.
Publicado: (2022)

Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers
por: Forkosh, Esther, et al.
Publicado: (2022)

Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population
por: Liu, Xinmin, et al.
Publicado: (2011)

Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico
por: Díaz-Velásquez, Clara Estela, et al.
Publicado: (2023)

Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients
por: Wu, Yiming, et al.
Publicado: (2023)

Genetic Complexity of Crohn’s Disease in Two Large Ashkenazi Jewish Families
por: Levine, Adam P., et al.
Publicado: (2016)

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
por: Hamada, Tsuyoshi, et al.
Publicado: (2019)

Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population
por: Fedick, Anastasia M, et al.
Publicado: (2015)

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry
por: Wang, Zhaoming, et al.
Publicado: (2012)

How old is this mutation? - a study of three Ashkenazi Jewish founder mutations
por: Greenwood, Celia MT, et al.
Publicado: (2010)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

A collaborative genetic carrier screening model for the British Ashkenazi Jewish community
por: Ziff, Monica, et al.
Publicado: (2021)

Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020)

A novel de novo PAX6 mutation in an Ashkenazi-Jewish family with aniridia
por: Bandah, Dikla, et al.
Publicado: (2008)

A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population
por: Schiff, Elena R., et al.
Publicado: (2018)

Whole Genome Sequencing Revealed Mutations in Two Independent Genes as the Underlying Cause of Retinal Degeneration in an Ashkenazi Jewish Pedigree
por: Gustafson, Kevin, et al.
Publicado: (2017)

Parental diabetes status reveals association of mitochondrial DNA haplogroup J1 with type 2 diabetes
por: Feder, Jeanette, et al.
Publicado: (2009)

Dissecting the genetic heterogeneity of myopia susceptibility in an Ashkenazi Jewish population using ordered subset analysis
por: Simpson, Claire L., et al.
Publicado: (2011)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
por: Hamel, Nancy, et al.
Publicado: (2003)

Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil
por: Koifman, Sergio, et al.
Publicado: (2001)

Hereditary cancer screening: Case reports and review of literature on ten Ashkenazi Jewish founder mutations
por: Cox, Devin M., et al.
Publicado: (2018)

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
por: Lehrer, S., et al.
Publicado: (1998)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease
por: Schiff, E. R., et al.
Publicado: (2018)

Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model
por: Blech, Ilana, et al.
Publicado: (2011)

Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study
por: Peter, Inga, et al.
Publicado: (2011)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ph6vstqfej69gfpmhnvh3aioo8